CCM
VRTX icon

Condor Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Condor Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89M Sell
6,461
-26
-0.4% -$12.1K 0.24% 83
2025
Q4 		$2.94M Sell
6,487
-20
-0.3% -$8.62K 0.24% 84
2025
Q3 		$2.55M Buy
6,507
+5
+0.1% +$2.09K 0.21% 90
2025
Q2 		$2.89M Sell
6,502
-26
-0.4% -$12K 0.25% 86
2025
Q1 		$3.16M Hold
6,528
– – 0.29% 77
2024
Q4 		$2.63M Sell
6,528
-30
-0.5% -$13.9K 0.23% 91
2024
Q3 		$3.05M Sell
6,558
-41
-0.6% -$19.7K 0.27% 78
2024
Q2 		$3.09M Sell
6,599
-281
-4% -$122K 0.3% 78
2024
Q1 		$2.88M Sell
6,880
-143
-2% -$60.5K 0.28% 83
2023
Q4 		$2.86M Sell
7,023
-75
-1% -$27.7K 0.31% 80
2023
Q3 		$2.47M Buy
7,098
+7
+0.1% +$2.45K 0.3% 73
2023
Q2 		$2.5M Sell
7,091
-135
-2% -$45.5K 0.3% 72
2023
Q1 		$2.28M Buy
7,226
+4
+0.1% +$1.2K 0.29% 77
2022
Q4 		$2.09M Buy
7,222
+36
+0.5% +$11K 0.26% 87
2022
Q3 		$2.08M Sell
7,186
-234
-3% -$67.3K 0.27% 84
2022
Q2 		$2.09M Buy
7,420
+131
+2% +$35.1K 0.27% 82
2022
Q1 		$1.9M Buy
7,289
+3,251
+81% +$772K 0.21% 101
2021
Q4 		$887K Sell
4,038
-3,433
-46% -$668K 0.1% 138
2021
Q3 		$1.35M Buy
7,471
+219
+3% +$42.8K 0.14% 126
2021
Q2 		$1.46M Sell
7,252
-21
-0.3% -$4.39K 0.16% 118
2021
Q1 		$1.56M Buy
+7,273
New +$1.6M 0.19% 107

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Condor Capital Management's VRTX Position: Q1 2026 in Review

Condor Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 0.4% in Q1 2026, selling an estimated $12.1K and leaving 6,461 shares worth $2.89M. The position accounts for 0.24% of the portfolio, ranked #83.

Condor Capital Management first reported a position in VRTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.16M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Condor Capital Management held 6,461 shares of Vertex Pharmaceuticals worth $2.89M as of Q1 2026.
  • Condor Capital Management sold 26 Vertex Pharmaceuticals shares in Q1 2026, an estimated $12.1K.
  • Vertex Pharmaceuticals made up 0.24% of Condor Capital Management's portfolio in Q1 2026, its #83 holding.
  • Condor Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Condor Capital Management's Vertex Pharmaceuticals position peaked at $3.16M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Condor Capital Management's 13F filing for Q1 2026, filed 11 May 2026.